U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C9H13N2O2.Br
Molecular Weight 261.116
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of PYRIDOSTIGMINE BROMIDE

SMILES

[Br-].CN(C)C(=O)OC1=C[N+](C)=CC=C1

InChI

InChIKey=VNYBTNPBYXSMOO-UHFFFAOYSA-M
InChI=1S/C9H13N2O2.BrH/c1-10(2)9(12)13-8-5-4-6-11(3)7-8;/h4-7H,1-3H3;1H/q+1;/p-1

HIDE SMILES / InChI
Molecular Formula C9H13N2O2
Molecular Weight 181.2117
Charge 1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE
Molecular Formula BrH
Molecular Weight 80.912
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

Unknown
86413
Substance Class Chemical
Created
by admin
on Sat Dec 16 16:01:26 UTC 2023
Edited
by admin
on Sat Dec 16 16:01:26 UTC 2023
Record UNII
KVI301NA53
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
PYRIDOSTIGMINE BROMIDE
EP   HSDB   INN   MART.   MI   ORANGE BOOK   USP   USP-RS   VANDF   WHO-DD   WHO-IP  
INN  
Official Name English
RO-1-5130
Code English
PYRIDOSTIGMINE BROMIDE [MI]
Common Name English
KALYMIN
Brand Name English
PYRIDINIUM, 3-(((DIMETHYLAMINO)CARBONYL)OXY)-1-METHYL-, BROMIDE (1:1)
Systematic Name English
PYRIDOSTIGMINE BROMIDE [ORANGE BOOK]
Common Name English
NSC-679759
Code English
PYRIDOSTIGMINI BROMIDUM [WHO-IP LATIN]
Common Name English
PYRIDOSTIGMINE BROMIDE [JAN]
Common Name English
REGONOL
Brand Name English
PYRIDOSTIGMINE BROMIDE [MART.]
Common Name English
PYRIDOSTIGMINE BROMIDE [EP IMPURITY]
Common Name English
3-Hydroxy-1-methylpyridinium bromide dimethylcarbamate
Systematic Name English
Pyridostigmine bromide [WHO-DD]
Common Name English
PYRIDOSTIGMINE BROMIDE [EP MONOGRAPH]
Common Name English
NSC-758435
Code English
KALIMIN
Brand Name English
PYRIDOSTIGMINE BROMIDE [WHO-IP]
Common Name English
MESTINON
Brand Name English
PYRIDINIUM, 3-(((DIMETHYLAMINO)CARBONYL)OXY)-1-METHYL-, BROMIDE
Systematic Name English
PYRIDOSTIGMINE BROMIDE [HSDB]
Common Name English
PYRIDOSTIGMINE BROMIDE [USP MONOGRAPH]
Common Name English
PYRIDOSTIGMINE BROMIDE [USP-RS]
Common Name English
pyridostigmine bromide [INN]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C47792
Created by admin on Sat Dec 16 16:01:26 UTC 2023 , Edited by admin on Sat Dec 16 16:01:26 UTC 2023
EPA PESTICIDE CODE 227702
Created by admin on Sat Dec 16 16:01:26 UTC 2023 , Edited by admin on Sat Dec 16 16:01:26 UTC 2023
Code System Code Type Description
DRUG BANK
DBSALT000190
Created by admin on Sat Dec 16 16:01:26 UTC 2023 , Edited by admin on Sat Dec 16 16:01:26 UTC 2023
PRIMARY
NCI_THESAURUS
C47697
Created by admin on Sat Dec 16 16:01:26 UTC 2023 , Edited by admin on Sat Dec 16 16:01:26 UTC 2023
PRIMARY
FDA UNII
KVI301NA53
Created by admin on Sat Dec 16 16:01:26 UTC 2023 , Edited by admin on Sat Dec 16 16:01:26 UTC 2023
PRIMARY
NSC
679759
Created by admin on Sat Dec 16 16:01:26 UTC 2023 , Edited by admin on Sat Dec 16 16:01:26 UTC 2023
PRIMARY
WHO INTERNATIONAL PHARMACOPEIA
PYRIDOSTIGMINE BROMIDE
Created by admin on Sat Dec 16 16:01:26 UTC 2023 , Edited by admin on Sat Dec 16 16:01:26 UTC 2023
PRIMARY Description: A white or almost white, crystalline powder; odour, agreeable, characteristic. Solubility: Soluble in less than 1 part of water and ethanol (~750 g/l) TS; practically insoluble in ether R. Category: Cholinergic. Storage: Pyridostigmine bromide should be kept in a well-closed container, protected from light. Additional information: Pyridostigmine bromide is deliquescent.Definition: Pyridostigmine bromide contains not less than 98.5% and not more than 101.0% of C9H13BrN2O2, calculated with reference to the dried substance.
MERCK INDEX
m9360
Created by admin on Sat Dec 16 16:01:26 UTC 2023 , Edited by admin on Sat Dec 16 16:01:26 UTC 2023
PRIMARY Merck Index
HSDB
3924
Created by admin on Sat Dec 16 16:01:26 UTC 2023 , Edited by admin on Sat Dec 16 16:01:26 UTC 2023
PRIMARY
ECHA (EC/EINECS)
202-929-9
Created by admin on Sat Dec 16 16:01:26 UTC 2023 , Edited by admin on Sat Dec 16 16:01:26 UTC 2023
PRIMARY
EPA CompTox
DTXSID9023540
Created by admin on Sat Dec 16 16:01:26 UTC 2023 , Edited by admin on Sat Dec 16 16:01:26 UTC 2023
PRIMARY
RXCUI
9001
Created by admin on Sat Dec 16 16:01:26 UTC 2023 , Edited by admin on Sat Dec 16 16:01:26 UTC 2023
PRIMARY RxNorm
PUBCHEM
7550
Created by admin on Sat Dec 16 16:01:26 UTC 2023 , Edited by admin on Sat Dec 16 16:01:26 UTC 2023
PRIMARY
RS_ITEM_NUM
1586009
Created by admin on Sat Dec 16 16:01:26 UTC 2023 , Edited by admin on Sat Dec 16 16:01:26 UTC 2023
PRIMARY
SMS_ID
100000091854
Created by admin on Sat Dec 16 16:01:26 UTC 2023 , Edited by admin on Sat Dec 16 16:01:26 UTC 2023
PRIMARY
ChEMBL
CHEMBL1115
Created by admin on Sat Dec 16 16:01:26 UTC 2023 , Edited by admin on Sat Dec 16 16:01:26 UTC 2023
PRIMARY
EVMPD
SUB10167MIG
Created by admin on Sat Dec 16 16:01:26 UTC 2023 , Edited by admin on Sat Dec 16 16:01:26 UTC 2023
PRIMARY
INN
278
Created by admin on Sat Dec 16 16:01:26 UTC 2023 , Edited by admin on Sat Dec 16 16:01:26 UTC 2023
PRIMARY
DAILYMED
KVI301NA53
Created by admin on Sat Dec 16 16:01:26 UTC 2023 , Edited by admin on Sat Dec 16 16:01:26 UTC 2023
PRIMARY
NSC
758435
Created by admin on Sat Dec 16 16:01:26 UTC 2023 , Edited by admin on Sat Dec 16 16:01:26 UTC 2023
PRIMARY
MESH
D011729
Created by admin on Sat Dec 16 16:01:26 UTC 2023 , Edited by admin on Sat Dec 16 16:01:26 UTC 2023
PRIMARY
CAS
101-26-8
Created by admin on Sat Dec 16 16:01:26 UTC 2023 , Edited by admin on Sat Dec 16 16:01:26 UTC 2023
PRIMARY
Related Record Type Details
Structure of PYRIDOSTIGMINE BROMIDE
BASIS OF STRENGTH->SUBSTANCE
ASSAY (TITRATION)
USP
Structure of PYRIDOSTIGMINE
PARENT -> SALT/SOLVATE
Structure of PYRIDOSTIGMINE BROMIDE
BASIS OF STRENGTH->SUBSTANCE
ASSAY (TITRATION)
EP
Related Record Type Details
Structure of PYRIDOSTIGMINE
ACTIVE MOIETY
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966